"Everybody wants to be successful," Ray Cohen said in an interview. "But the question I ask people is, 'Are you prepared to ...
Zacks Investment Research on MSN
BSX vs. RMD: Which medical device stock is the stronger play now?
Boston Scientific BSX and Resmed RMD are two major players in the global medical devices market, with market capitalizations ...
Boston Scientific’s BSX Neuromodulation business develops and manufactures devices to treat various neurological movement disorders and manage chronic pain. This segment reflects the company’s ...
Boston Scientific Corporation (NYSE:BSX) is one of the best healthcare AI stocks to buy now. On December 12, TD Cowen ...
Boston Scientific Corporation is rated a Hold with double-digit revenue growth and margin expansion. Learn more about BSX ...
Boston Scientific closes the year at historic highs, with investors refusing to liquidate even at these levels. The smooth upward movement of the stock indicates the quality of its investor base.
Boston Scientific BSX has a stretched valuation, reflected in its Value Score of C. Shares of the company are trading at a ...
Boston Scientific and the U.S. Food and Drug Administration were named in a product liability lawsuit on July 17 in California Central District Court over allegedly defective spinal cord stimulator ...
MARLBOROUGH, Mass., Jan. 7, 2022 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) today announced key data that will be featured at the 25th North American Neuromodulation Society (NANS) ...
* Sees Cosman Medical team and products will become part of Boston Scientific neuromodulation business * Expects net impact of this transaction on adjusted earnings per share to be break-even in 2016 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback